Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Benign Osteopetrosis

What is Benign Osteopetrosis?

Benign osteopetrosis is a rare genetic disorder characterized by increased bone density due to defective bone resorption. This condition occurs when osteoclasts, the cells responsible for breaking down bone tissue, fail to function properly, leading to overly dense but fragile bones. Unlike the more severe malignant (infantile) form of osteopetrosis, benign osteopetrosis, also known as autosomal dominant osteopetrosis (ADO), tends to have a milder clinical course. Some individuals with the benign form of osteopetrosis never experience adverse symptoms, and their diagnosis is only discovered as a result of x-rays. However, affected individuals may still experience bone pain, fractures, and other complications related to abnormal bone structure.

 

Synonyms

  • autosomal dominant osteopetrosis
  • Albers-Schönberg disease

Benign osteopetrosis is a rare genetic disorder characterized by increased bone density due to defective bone resorption. This condition occurs when osteoclasts, the cells responsible for breaking down bone tissue, fail to function properly, leading to overly dense but fragile bones. Unlike the more severe malignant (infantile) form of osteopetrosis, benign osteopetrosis, also known as autosomal dominant osteopetrosis (ADO), tends to have a milder clinical course. Some individuals with the benign form of osteopetrosis never experience adverse symptoms, and their diagnosis is only discovered as a result of x-rays. However, affected individuals may still experience bone pain, fractures, and other complications related to abnormal bone structure.

Acknowledgement of Benign Osteopetrosis has not been added yet.

Benign osteopetrosis is a rare disorder, with an estimated prevalence of 1 in 20,000 individuals. The condition is inherited in an autosomal dominant manner, meaning a person only needs one copy of the mutated gene from an affected parent to develop the disease (see Rareshare Guide on Genetic Inheritance). It is more common than the severe infantile form of osteopetrosis but still considered an uncommon skeletal disorder.

 

Name Abbreviation
autosomal dominant osteopetrosis ADO
Albers-Schönberg disease

There are eight known genetic factors that cause benign osteopetrosis. Mutations in the CLCN7 gene account for 75% of cases, other minor gene mutations account for about 5% of cases, and the other 20% of cases have unknown causes. Benign osteopetrosis is primarily caused by mutations in the CLCN7 gene, which encodes a chloride channel important for osteoclast function. Osteoclasts are a specialized cell tasked with breaking down and removing old bone tissue so that new bone can replace it. These mutations impair the ability of osteoclasts to reabsorb bone properly, leading to excessive bone accumulation. In about 5% of cases of benign osteopetrosis, mutations in other genes involved in bone remodeling may also be implicated. Unlike malignant osteopetrosis, benign osteopetrosis does not usually lead to life-threatening complications, but it can cause significant skeletal and neurological issues.

The severity of symptoms in benign osteopetrosis varies, but common features include:

  • Increased Bone Density: Bones appear abnormally dense on X-rays.

  • Frequent Bone Fractures: Despite being dense, the bones are brittle and prone to fractures, especially in the long bones.

  • Bone Pain: Chronic pain, particularly in the lower back, hips, and legs, due to increased bone mass and pressure on nerves.

  • Cranial Nerve Compression: In some cases, thickened bones in the skull can compress cranial nerves, leading to vision or hearing problems.

  • Osteoarthritis: Premature joint degeneration due to altered bone structure.

  • Mild Anemia or Bone Marrow Changes: Unlike the severe infantile form, significant bone marrow failure is rare but may still occur in some cases.

  • Shortened stature or slower growth

Benign osteopetrosis is often diagnosed incidentally when X-rays show characteristic increased bone density. A detailed clinical evaluation and family history help differentiate it from other bone disorders.

  • X-rays: Reveal generalized bone thickening, particularly in the spine, pelvis, and skull, with a "bone-within-a-bone" appearance.

  • Genetic Testing: Identifies mutations in the CLCN7 gene or other related genes to confirm the diagnosis.

  • Bone Density Scan (DXA): Shows increased bone mineral density, particularly in the spine and femur.

  • MRI or CT Scan: Can assess potential cranial nerve compression due to thickened skull bones.

  • Blood Tests: May show mildly low calcium levels and increased markers of bone turnover.

 There is no cure for benign osteopetrosis, and treatment focuses on managing symptoms and preventing complications:

  • Fracture Management: Patients with frequent fractures may require orthopedic care, including splints, casts, or surgery.

  • Pain Management: NSAIDs or other pain relievers may help alleviate bone pain.

  • Physical Therapy: Helps improve mobility, strengthen muscles, and reduce the risk of fractures.

  • Monitoring for Neurological Symptoms: Regular ophthalmologic and audiologic exams can help detect early signs of nerve compression.

  • Calcium and Vitamin D Supplementation: Helps maintain bone health and prevent secondary complications such as low calcium levels.

The prognosis for individuals with benign osteopetrosis is generally favorable, as it does not significantly reduce life expectancy. However, complications such as recurrent fractures, bone pain, and cranial nerve compression can impact quality of life. With proper monitoring and supportive treatment, most affected individuals can lead normal lives, though they may experience chronic bone-related issues. Genetic counseling may be recommended for affected families to understand the inheritance pattern and risks for future generations.

 

Tips or Suggestions of Benign Osteopetrosis has not been added yet.
Favorable Adult Stem Cell Therapy Created by skinny13
Last updated 16 Mar 2009, 05:33 AM

Posted by skinny13
16 Mar 2009, 05:33 AM

In this blog, Dr. Orchard indicates favorable results. http://www.scientificblogging.com/news/risk_assessment_for_stem_cell_transplantation_in_osteopetrosis_patients If this is true, one might draw some positive with a non-invasive food supplement, AFA, that when taken in a high concentrate enables us to release 25% more adult stems cells from our bone marrow to help us heal ourselves. Maureen

Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

I'm a Private Caregiver with a Social Work Degree in Healthcare and Gerontology.

 

 

My personal interests are our natural ability to increase the release of adult stem cells to heal...

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Favorable Adult Stem Cell Therapy

Created by skinny13 | Last updated 16 Mar 2009, 05:33 AM


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.